Table 3.

Cancer-specific mortality associations with ADI by cancer site and race

	All participants				Non-Hispanic White				Non-Hispanic Black
	n	events	Per-quintile HR (95% CI)	p-value	n	events	Per-quintile HR (95% CI)	p-value	n	events	Per-quintile HR (95% CI)	p-value
Breast cancer *	11926	1169	1.17 (1.12–1.23)	<0.0001	8965	754	1.16 (1.09–1.23)	<0.0001	2961	415	1.20 (1.09–1.31)	0.00013
Colorectal cancer **	6587	1928	1.08 (1.04–1.12)	<0.0001	4740	1314	1.08 (1.04–1.13)	0.00026	1847	614	1.06 (0.99–1.14)	0.114
Lung cancer *	9638	6290	1.06 (1.04–1.08)	<0.0001	7256	4741	1.06 (1.04–1.08)	<0.0001	2382	1549	1.07 (1.02–1.12)	0.00998
Prostate cancer **	11856	565	1.20 (1.13–1.29)	<0.0001	8176	344	1.16 (1.07–1.26)	0.00049	3680	221	1.31 (1.15–1.49)	<0.0001

^*Adjusted for race (overall model only), age at diagnosis included as strata variable

^**Adjusted for race (overall model only), adjusted for age at diagnosis